lysophosphatidic acid

lysophosphatidic acid is a lipid of Glycerophospholipids (GP) class. Lysophosphatidic acid is associated with abnormalities such as Atherosclerosis, Alzheimer's Disease, Asthma, Diabetes Mellitus, Non-Insulin-Dependent and Septicemia. The involved functions are known as Inflammation, Chemotaxis, Binding (Molecular Function), Polymerization and Inflammatory Response. Lysophosphatidic acid often locates in Cytoskeleton, Microfilaments, actin cytoskeleton, Extracellular and Structure of germinal center of lymph node. The associated genes with lysophosphatidic acid are TNF gene, MAPK3 gene, RHOA gene, CDC42 gene and ADRBK1 gene. The related lipids are lysophosphatidic acid, Lipopolysaccharides, Lysophosphatidylcholines, Lysophospholipids and Phosphatidic Acid. The related experimental models are Knock-out, Transgenic Model, Rodent Model and Disease model.

Cross Reference

Introduction

To understand associated biological information of lysophosphatidic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with lysophosphatidic acid?

lysophosphatidic acid is suspected in Atherosclerosis, Asthma, Dyslipidemias, Acute coronary syndrome, Pulmonary Fibrosis, Atherosclerosis of aorta and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with lysophosphatidic acid

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Adenocarcinoma D000230 166 associated lipids
Ovarian Neoplasms D010051 10 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Per page 10 20 50 | Total 47

PubChem Associated disorders and diseases

What pathways are associated with lysophosphatidic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with lysophosphatidic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with lysophosphatidic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with lysophosphatidic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with lysophosphatidic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with lysophosphatidic acid?

Knock-out

Knock-out are used in the study 'Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.' (Navab M et al., 2015) and Knock-out are used in the study 'Lysophospholipid mediators in the vasculature.' (Mueller P et al., 2015).

Transgenic Model

Transgenic Model are used in the study 'Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.' (Oda SK et al., 2013).

Rodent Model

Rodent Model are used in the study 'Lysophosphatidic acid mediates fibrosis in injured joints by regulating collagen type I biosynthesis.' (Wu L et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with lysophosphatidic acid

Download all related citations
Per page 10 20 50 100 | Total 1571
Authors Title Published Journal PubMed Link
Wang J et al. Plasma lipidomic signatures of spontaneous obese rhesus monkeys. 2019 Lipids Health Dis pmid:30621707
Lei L et al. The role of lysophosphatidic acid in the physiology and pathology of the skin. 2019 Life Sci. pmid:30584899
Yang F and Chen GX Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis. 2018 World J. Gastroenterol. pmid:30271079
Honjo M et al. Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes. 2018 Invest. Ophthalmol. Vis. Sci. pmid:29392315
Schmid R et al. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro. 2018 BMC Cancer pmid:30567518
Esmaeili A and Namazi S Is melatonin effective for pruritus caused by liver disease? 2018 Med. Hypotheses pmid:30396475
Inoue M et al. Addition of high load of lysophosphatidic acid to standard and high-fat chows causes no significant changes of its circulating and peripheral tissue levels but affects body weight and visceral fat mass of mice. 2018 Biofactors pmid:30368958
Srikanth M et al. Lysophosphatidic acid and its receptor LPA mediate carrageenan induced inflammatory pain in mice. 2018 Eur. J. Pharmacol. pmid:30321532
Huang YL et al. High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells. 2018 Cell. Physiol. Biochem. pmid:30317243
Thompson KE et al. Prevention and treatment of secretory diarrhea by the lysophosphatidic acid analog Rx100. 2018 Exp. Biol. Med. (Maywood) pmid:30253666
Kurabayashi N et al. The LPA-LPA4 axis is required for establishment of bipolar morphology and radial migration of newborn cortical neurons. 2018 Development pmid:30217809
Ninou I et al. Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis. 2018 Pulm Pharmacol Ther pmid:30201409
Lidgerwood GE et al. Roles of lysophosphatidic acid and sphingosine-1-phosphate in stem cell biology. 2018 Prog. Lipid Res. pmid:30196008
Gokul C et al. Lysophosphatidic acid enhances PGE2 to PGF2α ratio and nitric oxide level in nonpregnant buffalo uterus. 2018 Theriogenology pmid:30092374
Neary G et al. Development and biological evaluation of fluorophosphonate-modified hydroxyapatite for orthopaedic applications. 2018 J Mater Sci Mater Med pmid:30032456
Onallah H et al. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma. 2018 Virchows Arch. pmid:30032361
Fukasawa K et al. Qualitative and quantitative comparison of cyclic phosphatidic acid and its related lipid species in rat serum using hydrophilic interaction liquid chromatography with tandem-mass spectrometry. 2018 J Chromatogr A pmid:30017223
Zhou ZB et al. Lysophosphatidic Acid Promotes Expression and Activation of Matrix Metalloproteinase 9 (MMP9) in THP-1 Cells via Toll-Like Receptor 4/Nuclear Factor-κB (TLR4/NF-κB) Signaling Pathway. 2018 Med. Sci. Monit. pmid:30005060
Zhu X et al. Early development of porcine parthenogenetic embryos and reduced expression of primed pluripotent marker genes under the effect of lysophosphatidic acid. 2018 Reprod. Domest. Anim. pmid:29974990
Broström JM et al. Toluene diisocyanate exposure and autotaxin-lysophosphatidic acid signalling. 2018 Toxicol. Appl. Pharmacol. pmid:29940203
Ueda H et al. Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain. 2018 Pain pmid:29939962
Ramesh S et al. Autotaxin⁻Lysophosphatidic Acid Signaling in Alzheimer's Disease. 2018 Int J Mol Sci pmid:29933579
Jing X et al. Proliferation and differentiation of rat adipose‑derived stem cells are regulated by yes‑associated protein. 2018 Int. J. Mol. Med. pmid:29916531
Masago K et al. Lysophosphatidic acid receptor, LPA, regulates endothelial blood-brain barrier function: Implication for hepatic encephalopathy. 2018 Biochem. Biophys. Res. Commun. pmid:29778535
Shen X et al. Lysophosphatidic acid enhances neointimal hyperplasia following vascular injury through modulating proliferation, autophagy, inflammation and oxidative stress. 2018 Mol Med Rep pmid:29749484
Kim EY et al. Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients. 2018 Psychiatry Res pmid:29719272
Zou W et al. LC-Q-TOF-MS based plasma metabolomic profile of subclinical pelvic inflammatory disease: A pilot study. 2018 Clin. Chim. Acta pmid:29709453
Ho LTY et al. Lysophosphatidic Acid Induces ECM Production via Activation of the Mechanosensitive YAP/TAZ Transcriptional Pathway in Trabecular Meshwork Cells. 2018 Invest. Ophthalmol. Vis. Sci. pmid:29677358
Wang C et al. Lysophosphatidic acid induces neuronal cell death via activation of asparagine endopeptidase in cerebral ischemia-reperfusion injury. 2018 Exp. Neurol. pmid:29673933
Li C et al. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension. 2018 Pulm Pharmacol Ther pmid:29673911
Lidgerwood GE et al. Role of lysophosphatidic acid in the retinal pigment epithelium and photoreceptors. 2018 Biochim Biophys Acta Mol Cell Biol Lipids pmid:29660533
Sinderewicz E et al. Expression of genes for enzymes synthesizing lysophosphatidic acid, its receptors and follicle developmental factors derived from the cumulus-oocyte complex is dependent on the ovarian follicle type in cows. 2018 Anim. Reprod. Sci. pmid:29573844
D'Souza K et al. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance. 2018 Nutrients pmid:29570618
Jiang D et al. Elevated lysophosphatidic acid levels in the serum and cerebrospinal fluid in patients with multiple sclerosis: therapeutic response and clinical implication. 2018 Neurol. Res. pmid:29557721
Hwang SU et al. Lysophosphatidic acid increases in vitro maturation efficiency via uPA-uPAR signaling pathway in cumulus cells. 2018 Theriogenology pmid:29554602
Schoeman JC et al. Development and application of a UHPLC-MS/MS metabolomics based comprehensive systemic and tissue-specific screening method for inflammatory, oxidative and nitrosative stress. 2018 Anal Bioanal Chem pmid:29497765
Zhou T et al. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway. 2018 Cell. Physiol. Biochem. pmid:29466791
Afroz S et al. Lysophosphatidic acid in medicinal herbs enhances prostaglandin E and protects against indomethacin-induced gastric cell damage in vivo and in vitro. 2018 Prostaglandins Other Lipid Mediat. pmid:29462674
Okabe-Kado J et al. NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells. 2018 Leuk. Res. pmid:29407582
Takahashi K et al. Effects of LPA and LPA on the regulation of colony formation activity in colon cancer cells treated with anticancer drugs. 2018 J. Recept. Signal Transduct. Res. pmid:29369010
Riquelme-Guzmán C et al. Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis. 2018 Am. J. Physiol., Cell Physiol. pmid:29351412
Hidaka M et al. Three lysophosphatidic acids with a distinct long chain moiety differently affect cell differentiation of human colon epithelial cells to goblet cells. 2018 Life Sci. pmid:29412173
Rogers LC et al. Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy. 2018 Redox Biol pmid:29331665
Loskutov YV et al. LPA signaling is regulated through the primary cilium: a novel target in glioblastoma. 2018 Oncogene pmid:29321663
Bergasa NV The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years. 2018 Med. Hypotheses pmid:29317077
Bernacchioni C et al. Lysophosphatidic Acid Signaling Axis Mediates Ceramide 1-Phosphate-Induced Proliferation of C2C12 Myoblasts. 2018 Int J Mol Sci pmid:29300303
Wang X et al. Mutual regulation of the Hippo/Wnt/LPA/TGF‑β signaling pathways and their roles in glaucoma (Review). 2018 Int. J. Mol. Med. pmid:29286147
Nakajima S et al. 2-O-Carba-oleoyl cyclic phosphatidic acid induces glial proliferation through the activation of lysophosphatidic acid receptor. 2018 Brain Res. pmid:29278716
Baader M et al. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis. 2018 Br. J. Pharmacol. pmid:29197066
Takeda T et al. In vivo evidence for possible up-regulating roles of lysophosphatidic acid around fertilization in rats. 2018 J. Vet. Med. Sci. pmid:29162771
Szepanowski F et al. Lysophosphatidic acid propagates post-injury Schwann cell dedifferentiation through LPA signaling. 2018 Neurosci. Lett. pmid:29051083
Sinderewicz E et al. Bovine ovarian follicular growth and development correlate with lysophosphatidic acid expression. 2018 Theriogenology pmid:29028570
Chandra M et al. Cardiac-specific inactivation of LPP3 in mice leads to myocardial dysfunction and heart failure. 2018 Redox Biol pmid:28982073
Ray U and Roy SS Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling. 2018 FEBS J. pmid:28971574
Avula LR et al. Both NHERF3 and NHERF2 are necessary for multiple aspects of acute regulation of NHE3 by elevated Ca, cGMP, and lysophosphatidic acid. 2018 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:28882822
Schneider P et al. Altered synaptic phospholipid signaling in PRG-1 deficient mice induces exploratory behavior and motor hyperactivity resembling psychiatric disorders. 2018 Behav. Brain Res. pmid:28843862
Beltrame JS et al. Lysophosphatidic acid-triggered pathways promote the acquisition of trophoblast endovascular phenotype in vitro. 2018 J. Cell. Biochem. pmid:28657680
Tsukahara R et al. LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model. 2018 J. Pharmacol. Sci. pmid:29409686
LaPorte ME et al. Effects of LPA2R, LPA3R, or EP4R agonists on luteal or endometrial function in vivo or in vitro and sirtuin or EP1R, EP2R, EP3R or EP4R agonists on endometrial secretion of PGE and PGFin vitro. 2017 Theriogenology pmid:28460684
Fayyaz S et al. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity. 2017 Cell. Physiol. Biochem. pmid:28922661
Hino K et al. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva. 2017 J. Clin. Invest. pmid:28758906
Davies MR et al. Lysophosphatidic acid-induced RhoA signaling and prolonged macrophage infiltration worsens fibrosis and fatty infiltration following rotator cuff tears. 2017 J. Orthop. Res. pmid:27505847
Joncour A et al. Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors. 2017 J. Med. Chem. pmid:28731719
Valdés-Rives SA and González-Arenas A Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development. 2017 Mediators Inflamm. pmid:29430083
Plastira I et al. Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype. 2017 J Neuroinflammation pmid:29258556
Bae GH et al. Lysophosphatidic acid protects against acetaminophen-induced acute liver injury. 2017 Exp. Mol. Med. pmid:29217823
Benesch MGK et al. Lysophosphatidate Signaling: The Tumor Microenvironment's New Nemesis. 2017 Trends Cancer pmid:29120750
Li N et al. Lysophosphatidic acid enhances human umbilical cord mesenchymal stem cell viability without differentiation via LPA receptor mediating manner. 2017 Apoptosis pmid:28766061
Mirzoyan K et al. Lysophosphatidic Acid Protects Against Endotoxin-Induced Acute Kidney Injury. 2017 Inflammation pmid:28667502
Bosetti M et al. Injectable Graft Substitute Active on Bone Tissue Regeneration. 2017 Tissue Eng Part A pmid:28530130
Nsaibia MJ et al. OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-κB pathway. 2017 Cardiovasc. Res. pmid:28472283
Thorlakson HH et al. Lysophosphatidic acid induces expression of genes in human oral keratinocytes involved in wound healing. 2017 Arch. Oral Biol. pmid:28432900
Sordelli MS et al. Endogenous lysophosphatidic acid participates in vascularisation and decidualisation at the maternal-fetal interface in the rat. 2017 Reprod. Fertil. Dev. pmid:28376314
Zhang K et al. Hypertrophy and Fibrosis of the Ligamentum Flavum in Lumbar Spinal Stenosis is Associated With Increased Expression of LPA and LPAR1. 2017 Clin Spine Surg pmid:28323698
Taddeo EP et al. Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3. 2017 Sci Rep pmid:28273928
Ueda H Lysophosphatidic acid signaling is the definitive mechanism underlying neuropathic pain. 2017 Pain pmid:28151833
Michalczyk A et al. Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters. 2017 Lipids Health Dis pmid:28732508
Oh YS et al. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation. 2017 Exp. Mol. Med. pmid:28684865
Lötsch J et al. Machine-Learned Data Structures of Lipid Marker Serum Concentrations in Multiple Sclerosis Patients Differ from Those in Healthy Subjects. 2017 Int J Mol Sci pmid:28590455
Rancoule C et al. Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index. 2017 Oncotarget pmid:28402936
Rojas JM et al. Phospholipase D from Loxosceles laeta Spider Venom Induces IL-6, IL-8, CXCL1/GRO-α, and CCL2/MCP-1 Production in Human Skin Fibroblasts and Stimulates Monocytes Migration. 2017 Toxins (Basel) pmid:28379166
Zhang JB et al. Plasma Phospholipids are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients. 2017 Curr Alzheimer Res pmid:27915992
Chen L et al. Lysophosphatidic acid directly induces macrophage-derived foam cell formation by blocking the expression of SRBI. 2017 Biochem. Biophys. Res. Commun. pmid:28765047
Tsukahara T et al. Lysophosphatidic acid signaling regulates the KLF9-PPARγ axis in human induced pluripotent stem cell-derived neurons. 2017 Biochem. Biophys. Res. Commun. pmid:28716732
An D et al. CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation. 2017 J. Biol. Chem. pmid:28705936
Lopane C et al. Implications of the lysophosphatidic acid signaling axis in liver cancer. 2017 Biochim Biophys Acta Rev Cancer pmid:28591560
Sarker R et al. Phosphorylation of NHE3-S regulates NHE3 activity through the formation of multiple signaling complexes. 2017 Mol. Biol. Cell pmid:28495796
Contursi A et al. Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting. 2017 Cell. Mol. Life Sci. pmid:28488110
Nikolaou A et al. Autotaxin inhibitors: a patent review (2012-2016). 2017 Expert Opin Ther Pat pmid:28447479
McDougall JJ et al. Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain. 2017 Osteoarthr. Cartil. pmid:27651153
Moreno-Fernández RD et al. maLPA1-null mice as an endophenotype of anxious depression. 2017 Transl Psychiatry pmid:28375206
Thirunavukkarasu K et al. Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain. 2017 Osteoarthr. Cartil. pmid:27638130
Saulnier-Blache JS et al. Urinary lysophopholipids are increased in diabetic patients with nephropathy. 2017 J. Diabetes Complicat. pmid:28506691
Sakai N et al. Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor. 2017 Kidney Int. pmid:27927603
Kang TS et al. A rhodium(III)-based inhibitor of autotaxin with antiproliferative activity. 2017 Biochim Biophys Acta Gen Subj pmid:27888146
Niss Arfelt K et al. Signaling via G proteins mediates tumorigenic effects of GPR87. 2017 Cell. Signal. pmid:27865873
Sattikar A et al. Endogenous lysophosphatidic acid (LPA ) receptor agonists demonstrate ligand bias between calcium and ERK signalling pathways in human lung fibroblasts. 2017 Br. J. Pharmacol. pmid:27864940
Sinderewicz E et al. Lysophosphatidic acid expression in theca cells depends on the type of bovine ovarian follicle. 2017 Reprod. Domest. Anim. pmid:27644923
Velasco M et al. Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain. 2017 Neuropharmacology pmid:27059127
Cheng L et al. Interaction between mDia1 and ROCK in Rho-induced migration and adhesion of human dental pulp cells. 2017 Int Endod J pmid:26609804